Skip to Main Navigation
Skip to the Content
Skip to the Footer
Menu
Request An Appointment
Donate
Patient Portals
Find Care
Find Care
Request An Appointment
Find a Doctor
Locations
Get Screened
Find Care
Live Wells
Barbershop Bash
Find a Specialty or Treatment
Find Care
Cancer Types
Services & Treatments
Clinical Trials
Northshore Breast Cancer Specialty Program
Understanding Cancer Care
What to know about ovarian and uterine cancer
Patients & Families
Patients & Families
Patient Portal
Patients & Families
Pay My Bill
Support & Survivorship
Patients & Families
Support and Survivorship
Financial Services
Helping Hands
Health Equity
Resources for Families & Caregivers
Medical Records
Upcoming Events
Give & Support
Give & Support
Donate
Ways to Give
Give & Support
Planned Giving
Endowment
Grateful Patient
Corporate Giving
Volunteer
Foundation
Donor Circles
Gratitude Gram Wall
Giving Events
Meet the Philanthropy Team
About Us
About Us
Our Story
Our Leadership Team
Job Opportunities
Medical Physics
Media & Blogs
About Us
Blog
Press Releases
Patient Stories
June 1, 2016
Mike VI taken for Stereotactic Radiation
LSU’s Mike VI taken to Mary Bird Perkins Cancer Center for stereotactic radiotherapy
(Baton Rouge, La.)Â
On June 1, LSU’s live tiger mascot, Mike VI, was anesthetized and taken to Mary Bird Perkins Cancer Center for stereotactic radiotherapy, or SRT, which delivered a precise, concentrated dose of radiation to Mike’s cancer. The radiation dose was delivered in a single treatment and optimized to avoid normal tissues surrounding Mike’s cancer in order to reduce the risk complications. The Elekta Versa HD was used for Mike’s treatment and is one of the most advanced radiation therapy systems available today for delivering the type of treatment Mike needed. This treatment is not curative but should extend Mike’s life and allow him to live comfortably for some time. Mike VI was diagnosed with a spindle cell sarcoma, a type of cancer, after he was taken to the LSU School of Veterinary Medicine for a physical examination and diagnostic studies on May 12. On May 28, Mike underwent radiation treatment simulation to create the devices that were used to help position Mike for SRT and to acquire the CT images used to map the tumor in his face during treatment planning. It appears at this time that Mike will only need to undergo one treatment. Eventually, the radiation-resistant cells remaining in the tumor will resume growth. As for timeframes, it is estimated that without treatment Mike VI could live 1-2 months; with treatment, perhaps 1-2 years. The Cancer Center was selected to provide radiation therapy due to its longstanding relationship with the LSU School of Veterinary Medicine. For years, the Cancer Center’s medical physicists have provided consultation and approval for animals receiving radiation treatment at LSU. Additionally, the Cancer Center offers the advanced technology and facilities necessary for Mike’s SRT treatments, which have occurred outside of normal business hours. Following SRT, Mike was taken back to his night house on the LSU campus. Mike VI is not expected to experience more than mild and transient (temporary) side effects from the treatment. He is awake but will remain inside as he recovers from the general anesthesia necessary for the treatment. Mike will be closely monitored by LSU’s attending veterinarian David Baker, DVM, PhD, and his veterinary student caretakers. To get updates on Mike’s condition, please go to
www.lsu.edu/miketiger
or visit his social media pages (
facebook.com/MikeTigerVI
and
@MikeTigerVI
).
The LSU School of Veterinary Medicine is one of only 30 veterinary schools in the U.S. and the only one in Louisiana. The LSU SVM is dedicated to improving the lives of people and animals through education, research and service. We teach. We heal. We discover. We protect.
Media Contact: Ginger Guttner, Director of Public Relations LSU School of Veterinary Medicine 225-578-9922 or ginger@lsu.edu
facebook.com/LSUVTH
 |Â
Instagram.com/LSUVetMed
 |Â
twitter.com/LSUVetMed
 |Â
facebook.com/LSUSVM
Sign Up for our newsletter
Enter Search Term
Search